Aili He

2.4k total citations
46 papers, 974 citations indexed

About

Aili He is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Aili He has authored 46 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Hematology and 13 papers in Immunology. Recurrent topics in Aili He's work include CAR-T cell therapy research (12 papers), Multiple Myeloma Research and Treatments (7 papers) and Immunotherapy and Immune Responses (7 papers). Aili He is often cited by papers focused on CAR-T cell therapy research (12 papers), Multiple Myeloma Research and Treatments (7 papers) and Immunotherapy and Immune Responses (7 papers). Aili He collaborates with scholars based in China, Ireland and Japan. Aili He's co-authors include Wanhong Zhao, Wanggang Zhang, Jinsong Hu, Yinxia Chen, Xing-Mei Cao, Pengyu Zhang, Dan Zhang, Lei Lei, Michael O’Dwyer and Yilin Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Aili He

43 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aili He China 17 397 343 256 223 207 46 974
Usanarat Anurathapan Thailand 17 317 0.8× 539 1.6× 226 0.9× 186 0.8× 76 0.4× 113 1.1k
Chung-Che Chang United States 18 231 0.6× 529 1.5× 236 0.9× 139 0.6× 63 0.3× 49 1.0k
Timothy A. Driscoll United States 15 257 0.6× 159 0.5× 213 0.8× 411 1.8× 160 0.8× 35 976
Katherine Woods Australia 16 257 0.6× 349 1.0× 274 1.1× 94 0.4× 83 0.4× 42 801
Damien Roos‐Weil France 14 189 0.5× 251 0.7× 200 0.8× 191 0.9× 140 0.7× 82 896
Nicola Tumino Italy 25 420 1.1× 820 2.4× 1.3k 5.1× 113 0.5× 64 0.3× 56 1.9k
Alexandros Spyridonidis Greece 20 281 0.7× 272 0.8× 234 0.9× 594 2.7× 41 0.2× 75 1.1k
Sean Agbor-Enoh United States 17 326 0.8× 204 0.6× 224 0.9× 33 0.1× 84 0.4× 80 1.2k
Shotaro Iwamoto Japan 15 266 0.7× 508 1.5× 680 2.7× 294 1.3× 45 0.2× 65 1.2k
Sonia Cellot Canada 14 410 1.0× 184 0.5× 125 0.5× 276 1.2× 64 0.3× 44 787

Countries citing papers authored by Aili He

Since Specialization
Citations

This map shows the geographic impact of Aili He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aili He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aili He more than expected).

Fields of papers citing papers by Aili He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aili He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aili He. The network helps show where Aili He may publish in the future.

Co-authorship network of co-authors of Aili He

This figure shows the co-authorship network connecting the top 25 collaborators of Aili He. A scholar is included among the top collaborators of Aili He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aili He. Aili He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Linlin, Yi Yang, Guodong Li, et al.. (2025). Arachidonic acid promotes myeloid differentiation of splenic CD45- Ter119+ cells in myeloproliferative neoplasm. Journal of Cancer. 16(7). 2289–2297.
2.
Wang, Yiwen, et al.. (2024). The significance of RB1 in multiple myeloma. Frontiers in Immunology. 15. 1415972–1415972.
3.
Yang, Rui, Yun Yang, Rui Liu, et al.. (2024). Advances in CAR-NK cell therapy for hematological malignancies. Frontiers in Immunology. 15. 1414264–1414264. 16 indexed citations
4.
Liu, Hailing, Wanggang Zhang, Aili He, et al.. (2023). TAFRO syndrome was effectively treated with an inexpensive novel scheme: A case report. SHILAP Revista de lepidopterología. 11(2). e6183–e6183. 1 indexed citations
5.
Shen, Ying, Jie Liu, Baiyan Wang, et al.. (2023). Serum soluble BCMA can be used to monitor relapse of multiple myeloma patients after chimeric antigen receptor T-cell immunotherapy. Current Research in Translational Medicine. 71(2). 103378–103378. 10 indexed citations
6.
Liu, Zeshi, Lu Bai, Jiayun Liu, et al.. (2021). Parallel Validation of the NG-Test Carba 5 and the Xpert Carba-R for Detection and Characterization of Carbapenem-Resistant Enterobacterales Causing Bloodstream Infections. Journal of Molecular Diagnostics. 23(8). 1007–1014. 12 indexed citations
7.
Bai, Ju, Jianli Wang, Yun Yang, et al.. (2021). Identification of HLA-A*0201-restricted CTL Epitopes for MLAA-34-specific Immunotherapy for Acute Monocytic Leukemia. Journal of Immunotherapy. 44(4). 141–150. 2 indexed citations
8.
Liu, Hailing, Yuqiang Ji, Xiaorong Ma, et al.. (2021). Effects of CpG oligodeoxynucleotides on the differentiation of Treg/Th17 cells. Molecular Immunology. 132. 199–208. 10 indexed citations
9.
Wang, Yanmeng, Nan Lv, Dan Zhang, et al.. (2020). Hypoxia Impairs NK Cell Cytotoxicity through SHP‐1‐Mediated Attenuation of STAT3 and ERK Signaling Pathways. Journal of Immunology Research. 2020(1). 4598476–4598476. 58 indexed citations
10.
Peng, Yue, Peihua Zhang, Xiaman Wang, et al.. (2020). IGF-1 promotes multiple myeloma progression through PI3K/Akt-mediated epithelial-mesenchymal transition. Life Sciences. 249. 117503–117503. 32 indexed citations
11.
Wang, Baiyan, Jie Liu, Wanhong Zhao, et al.. (2020). Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease--a Single Institution Observation in China. Blood. 136(Supplement 1). 6–6. 16 indexed citations
12.
Zhang, Dan, Rui Guo, Lei Lei, et al.. (2020). Frontline Science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes. Journal of Leukocyte Biology. 109(1). 13–22. 208 indexed citations
13.
Chen, Hongli, Fangxia Wang, Pengyu Zhang, et al.. (2019). Management of cytokine release syndrome related to CAR-T cell therapy. Frontiers of Medicine. 13(5). 610–617. 77 indexed citations
14.
Liu, Zhao, Aili He, Yinxia Chen, et al.. (2019). Visfatin promotes the malignancy of human acute myeloid leukemia cells via regulation of IL-17. European Journal of Pharmacology. 853. 103–110. 4 indexed citations
15.
Shen, Ying, Yuandong Feng, Hongli Chen, et al.. (2018). Focusing on long non-coding RNA dysregulation in newly diagnosed multiple myeloma. Life Sciences. 196. 133–142. 20 indexed citations
16.
Shen, Ying, Aili He, Fangxia Wang, et al.. (2017). Granulocyte colony stimulating factor priming chemotherapy is more effective than standard chemotherapy as salvage therapy in relapsed acute myeloid leukemia. Medicina Clínica. 151(9). 339–344. 2 indexed citations
17.
Wang, Fangxia, Wanggang Zhang, Aili He, et al.. (2016). Effect of granulocyte colony-stimulating factor priming combined with low-dose cytarabine and homoharringtonine in higher risk myelodysplastic syndrome patients. Leukemia Research. 48. 57–61. 6 indexed citations
18.
Li, Jing, Ju Bai, Liufang Gu, et al.. (2014). Prediction and identification of HLA-A*0201-restricted epitopes from leukemia-associated protein MLAA-22 which elicit cytotoxic T lymphocytes. Medical Oncology. 31(12). 293–293. 2 indexed citations
19.
He, Aili, et al.. (2011). Anti-tumor immune responses in immune-reconstituted mice injected with a tumor vaccine. Medical Oncology. 29(3). 2261–2269. 2 indexed citations
20.
Zhang, Wanggang, Fangxia Wang, Yinxia Chen, et al.. (2007). Combination chemotherapy with low‐dose cytarabine, homoharringtonine, and granulocyte colony‐stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia. American Journal of Hematology. 83(3). 185–188. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Usanarat Anurathapan Breakdown of academic impact, for papers by Chung-Che Chang Breakdown of academic impact, for papers by Timothy A. Driscoll Breakdown of academic impact, for papers by Katherine Woods Breakdown of academic impact, for papers by Damien Roos‐Weil Breakdown of academic impact, for papers by Nicola Tumino Breakdown of academic impact, for papers by Alexandros Spyridonidis Breakdown of academic impact, for papers by Sean Agbor-Enoh Breakdown of academic impact, for papers by Shotaro Iwamoto Breakdown of academic impact, for papers by Sonia Cellot
Rankless by CCL
2026